Please use this identifier to cite or link to this item:
https://doi.org/10.1186/2251-6581-12-46
Title: | Frequency and genetic spectrum of maturity-onset diabetes of the young (MODY) in southern New Zealand | Authors: | Wheeler, B.J Patterson, N Love, D.R Prosser, D Tomlinson, P Taylor, B.J Manning, P |
Keywords: | gliclazide glucokinase glucose hepatocyte nuclear factor 1beta insulin insulin aspart isophane insulin acanthosis nigricans adolescent Article case report child chromosome 17q chromosome deletion dehydration exon face dysmorphia female GCK gene gene loss gene mutation genetic screening glucose blood level HNF1B gene human hyperglycemia hypernatremia insulin dependent diabetes mellitus insulin resistance intellectual impairment male morning dosage mucocutaneous candidiasis New Zealand non insulin dependent diabetes mellitus prevalence school child |
Issue Date: | 2013 | Citation: | Wheeler, B.J, Patterson, N, Love, D.R, Prosser, D, Tomlinson, P, Taylor, B.J, Manning, P (2013). Frequency and genetic spectrum of maturity-onset diabetes of the young (MODY) in southern New Zealand. Journal of Diabetes and Metabolic Disorders 12 (1) : 46. ScholarBank@NUS Repository. https://doi.org/10.1186/2251-6581-12-46 | Rights: | Attribution 4.0 International | Abstract: | Maturity-Onset Diabetes of the Young (MODY) is a monogenic form of diabetes, consisting of a heterogeneous group of autosomal dominant inherited disorders. Typical onset is in individuals prior to twenty five years, and presentation can mimic type 1 or 2 diabetes. Molecular genetic testing can allow precise identification of the different MODY sub-types. Making a specific diagnosis of MODY can have important implications for the guidance of appropriate treatment, prognosis and genetic counselling.We present the cases of three children and their families diagnosed with MODY over the past two years. These families highlight the features of three of the more common MODY subtypes, including two with novel mutations, one of which segregates in a kindred that is strongly affected by both MODY and classic autoimmune mediated diabetes. To date, we have identified a prevalence of MODY in the paediatric diabetes population of the lower South Island, New Zealand, of approximately 2.5%. This prevalence, along with increasing access to molecular genetic testing, highlights the importance of consideration of MODY in atypical diabetes presentations in the paediatric/adolescent population. © 2013 Wheeler et al.; licensee BioMed Central Ltd. | Source Title: | Journal of Diabetes and Metabolic Disorders | URI: | https://scholarbank.nus.edu.sg/handle/10635/183187 | ISSN: | 22516581 | DOI: | 10.1186/2251-6581-12-46 | Rights: | Attribution 4.0 International |
Appears in Collections: | Staff Publications Elements |
Show full item record
Files in This Item:
File | Description | Size | Format | Access Settings | Version | |
---|---|---|---|---|---|---|
10_1186_2251-6581-12-46.pdf | 96.23 kB | Adobe PDF | OPEN | None | View/Download |
This item is licensed under a Creative Commons License